But despite its Innate Immunotherapeutics profile , Innate has some surprisingly influential boosters in Washington .The congressional liaison to    Donald J. Trump ’s transition team , Representative Chris Collins , Republican of New York , is the company ’s largest shareholder and sits on the board .Representative Tom Price of Georgia , Mr.   Donald J. Trump nominee to be secretary of health and human services , purchased shares of Innate four times in 2015 and 2016 , according to congressional financial disclosures , totaling between $ 60 , 000 and $ 110 , 000 .Other Washington power players with investments in the company the company’s Hook , Mr. Collins ’s chief of staff , who is a top shareholder , and Bill Paxon , a Washington lobbyist and Washington congressman , according to company filings and congressional financial disclosures .